Want to join the conversation?
Biotechnology company $CARA announced positive topline results from its Phase 2a trial of oral CR845 in patients with osteoarthritis of the knee or hip. All tablet strengths were generally well tolerated with no drug-related SAEs. Based on these results, $CARA plans to conduct a larger double-blind, placebo-controlled Phase 2b trial in 2016.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.